1. The effects of valproic acid on the mRNA expression of Natriuretic Peptide Receptor A and KQT-like subfamily Q-1 in human colon cancer cell lines
   Mona Hajikazemi et al, 2018, Alexandria Journal of Medicine CrossRef
2. Cellular physiological approach for treatment of gastric cancer
   Atsushi Shiozaki, 2014, World Journal of Gastroenterology CrossRef
3. Ion channels or aquaporins as novel molecular targets in gastric cancer
   Jianling Xia et al, 2017, Molecular Cancer CrossRef
4. ANP reduced Hedgehog signaling-mediated activation of matrix metalloproteinase-9 in gastric cancer cell line MGC-803
   Chun-Hui Li et al, 2020, Gene CrossRef
5. Atrial natriuretic peptide: An old hormone or a new cytokine?
   Paolo De Vito, 2014, Peptides CrossRef
6. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease
   José Tuñón et al, 2015, PLOS ONE CrossRef
7. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation
   Ambili Menon et al, 2019, Journal of Molecular and Cellular Cardiology CrossRef
8. RETRACTED: Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression
   Xu Qi et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
9. Role of ion channels in gastrointestinal cancer
   Kyle J Anderson et al, 2019, World Journal of Gastroenterology CrossRef
10. Pathophysiological role of ion channels and transporters in gastrointestinal mucosal diseases
    Zilin Deng et al, 2021, Cellular and Molecular Life Sciences CrossRef
11. Five‑long non‑coding RNA risk score system for the effective prediction of gastric cancer patient survival
    Zunqi Hu et al, 2019, Oncology Letters CrossRef
12. Mutation in NPPA causes atrial fibrillation by activating inflammation and cardiac fibrosis in a knock‐in rat model
    Chen Cheng et al, 2019, The FASEB Journal CrossRef
13. N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
    José Tuñón et al, 2021, Journal of Clinical Medicine CrossRef
14. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer
    Hua Wei et al, 2018, Future Oncology CrossRef
15. Physiological Significance of Ion Transporters and Channels in the Stomach and Pathophysiological Relevance in Gastric Cancer
    Dumin Yuan et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
16. Hypermethylated KCNQ1 acts as a tumor suppressor in hepatocellular carcinoma
    Haiyan Fan et al, 2018, Biochemical and Biophysical Research Communications CrossRef
17. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel
    Jia Chen et al, 2022, Orphanet Journal of Rare Diseases CrossRef
18. Natriuretic peptides: Another tool for the management of cancer?
    Jorge Balaguer et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
19. The Role of Potassium Channel Gates in the Electrophysiology of the Human Gastric Smooth Muscle Cell
    Hossein Taghadosi et al, 2022, Gene, Cell and Tissue CrossRef
20. The role of metal ions in the occurrence, progression, drug resistance, and biological characteristics of gastric cancer
    Pengtuo Xiao et al, 2024, Frontiers in Pharmacology CrossRef
21. Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity
    Huafeng Fu et al, 2022, Cancers CrossRef
22. Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice
    Vimala Subramanian et al, 2014, European Journal of Pharmacology CrossRef
23. Levels of NT‑proBNP in patients with cancer
    Jozef Chovanec Jr et al, 2023, Oncology Letters CrossRef